Number of the records: 1  

ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis

  1. 1.
    SYSNO ASEP0544584
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis
    Author(s) Žbodáková, Olga (UMG-J)
    Chalupský, Karel (UMG-J)
    Sarnová, Lenka (UMG-J)
    Kašpárek, Petr (UMG-J)
    Jiroušková, Markéta (UMG-J) RID, ORCID
    Gregor, Martin (UMG-J) RID, ORCID
    Sedláček, Radislav (UMG-J) RID
    Number of authors7
    Article number11414
    Source TitleScientific Reports. - : Nature Publishing Group - ISSN 2045-2322
    Roč. 11, č. 1 (2021)
    Number of pages14 s.
    Publication formOnline - E
    Languageeng - English
    CountryGB - United Kingdom
    Keywordstumor-necrosis-factor ; epidermal-growth-factor ; factor-alpha ; partial-hepatectomy ; factor hgf ; receptor ; inflammation ; disintegrin ; activation ; resistance
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsLM2015040 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    LM2018126 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    ED2.1.00/19.0395 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingOpen access
    Institutional supportUMG-J - RVO:68378050
    UT WOS000660844500011
    DOI10.1038/s41598-021-90716-3
    AnnotationADAM10 and ADAM17 are proteases that affect multiple signalling pathways by releasing molecules from the cell surface. As their substrate specificities partially overlaps, we investigated their concurrent role in liver regeneration and fibrosis, using three liver-specific deficient mouse lines: ADAM10- and ADAM17-deficient lines, and a line deficient for both proteases. In the model of partial hepatectomy, double deficient mice exhibited decreased AKT phosphorylation, decreased release of EGFR activating factors and lower shedding of HGF receptor c-Met. Thus, simultaneous ablation of ADAM10 and ADAM17 resulted in inhibited EGFR signalling, while HGF/c-Met signalling pathway was enhanced. In contrast, antagonistic effects of ADAM10 and ADAM17 were observed in the model of chronic CCl4 intoxication. While ADAM10-deficient mice develop more severe fibrosis manifested by high ALT, AST, ALP and higher collagen deposition, combined deficiency of ADAM10 and ADAM17 surprisingly results in comparable degree of liver damage as in control littermates. Therefore, ADAM17 deficiency is not protective in fibrosis development per se, but can ameliorate the damaging effect of ADAM10 deficiency on liver fibrosis development. Furthermore, we show that while ablation of ADAM17 resulted in decreased shedding of TNF RI, ADAM10 deficiency leads to increased levels of soluble TNF RI in serum. In conclusion, hepatocyte-derived ADAM10 and ADAM17 are important regulators of growth receptor signalling and TNF RI release, and pathological roles of these proteases are dependent on the cellular context.
    WorkplaceInstitute of Molecular Genetics
    ContactNikol Škňouřilová, nikol.sknourilova@img.cas.cz, Tel.: 241 063 217
    Year of Publishing2022
    Electronic addresshttps://www.nature.com/articles/s41598-021-90716-3
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.